title: IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
abstract: IGF-1 has been shown to promote proliferation of normal epithelial breast cells, and the IGF pathway has also been linked to mammary carcinogenesis in animal models. We comprehensively examined the association between common genetic variation in the IGF1, IGFBP1, and IGFBP3 genes in relation to circulating IGF-I and IGFBP-3 levels and breast cancer risk within the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). This analysis included 6,912 breast cancer cases and 8,891 matched controls (n = 6,410 for circulating IGF-I and 6,275 for circulating IGFBP-3 analyses) comprised primarily of Caucasian women drawn from six large cohorts. Linkage disequilibrium and haplotype patterns were characterized in the regions surrounding IGF1 and the genes coding for two of its binding proteins, IGFBP1 and IGFBP3. In total, thirty haplotype-tagging single nucleotide polymorphisms (htSNP) were selected to provide high coverage of common haplotypes; the haplotype structure was defined across four haplotype blocks for IGF1 and three for IGFBP1 and IGFBP3. Specific IGF1 SNPs individually accounted for up to 5% change in circulating IGF-I levels and individual IGFBP3 SNPs were associated up to 12% change in circulating IGFBP-3 levels, but no associations were observed between these polymorphisms and breast cancer risk. Logistic regression analyses found no associations between breast cancer and any htSNPs or haplotypes in IGF1, IGFBP1, or IGFBP3. No effect modification was observed in analyses stratified by menopausal status, family history of breast cancer, body mass index, or postmenopausal hormone therapy, or for analyses stratified by stage at diagnosis or hormone receptor status. In summary, the impact of genetic variation in IGF1 and IGFBP3 on circulating IGF levels does not appear to substantially influence breast cancer risk substantially among primarily Caucasian postmenopausal women.
authors.affiliation: Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, Georgia, United States of America. apatel@cancer.org
authors.forename: Alpa V
authors.initials: AV
authors.lastname: Patel
authors.forename: Iona
authors.initials: I
authors.lastname: Cheng
authors.forename: Federico
authors.initials: F
authors.lastname: Canzian
authors.forename: Loïc
authors.initials: L
authors.lastname: Le Marchand
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Thun
authors.forename: Christine D
authors.initials: CD
authors.lastname: Berg
authors.forename: Julie
authors.initials: J
authors.lastname: Buring
authors.forename: Eugenia E
authors.initials: EE
authors.lastname: Calle
authors.forename: Stephen
authors.initials: S
authors.lastname: Chanock
authors.forename: Francoise
authors.initials: F
authors.lastname: Clavel-Chapelon
authors.forename: David G
authors.initials: DG
authors.lastname: Cox
authors.forename: Miren
authors.initials: M
authors.lastname: Dorronsoro
authors.forename: Laure
authors.initials: L
authors.lastname: Dossus
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Haiman
authors.forename: Susan E
authors.initials: SE
authors.lastname: Hankinson
authors.forename: Brian E
authors.initials: BE
authors.lastname: Henderson
authors.forename: Robert
authors.initials: R
authors.lastname: Hoover
authors.forename: David J
authors.initials: DJ
authors.lastname: Hunter
authors.forename: Rudolf
authors.initials: R
authors.lastname: Kaaks
authors.forename: Laurence N
authors.initials: LN
authors.lastname: Kolonel
authors.forename: Peter
authors.initials: P
authors.lastname: Kraft
authors.forename: Jakob
authors.initials: J
authors.lastname: Linseisen
authors.forename: Eiliv
authors.initials: E
authors.lastname: Lund
authors.forename: Jonas
authors.initials: J
authors.lastname: Manjer
authors.forename: Catherine
authors.initials: C
authors.lastname: McCarty
authors.forename: Petra H M
authors.initials: PH
authors.lastname: Peeters
authors.forename: Malcolm C
authors.initials: MC
authors.lastname: Pike
authors.forename: Michael
authors.initials: M
authors.lastname: Pollak
authors.forename: Elio
authors.initials: E
authors.lastname: Riboli
authors.forename: Daniel O
authors.initials: DO
authors.lastname: Stram
authors.forename: Anne
authors.initials: A
authors.lastname: Tjonneland
authors.forename: Ruth C
authors.initials: RC
authors.lastname: Travis
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Trichopoulos
authors.forename: Rosario
authors.initials: R
authors.lastname: Tumino
authors.forename: Meredith
authors.initials: M
authors.lastname: Yeager
authors.forename: Regina G
authors.initials: RG
authors.lastname: Ziegler
authors.forename: Heather Spencer
authors.initials: HS
authors.lastname: Feigelson
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics*; D015331:Cohort Studies; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D018970:Insulin-Like Growth Factor Binding Protein 1 / Q000097:blood / Q000235:genetics*; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood / Q000235:genetics*; D007334:Insulin-Like Growth Factor I / Q000235:genetics* / Q000378:metabolism; D015810:Linkage Disequilibrium; D008297:Male; D011110:Polymorphism, Genetic; D011471:Prostatic Neoplasms / Q000235:genetics; D012307:Risk Factors
chemical_list: D018970:Insulin-Like Growth Factor Binding Protein 1; D018972:Insulin-Like Growth Factor Binding Protein 3; D007334:Insulin-Like Growth Factor I